At the beginning of the event, Boehringer Ingelheim will present its research focus and partnering activities. In addition, BI’s Venture Fund will introduce its investment strategy and focus. Following this with a snack, representatives from Boehringer Ingelheim's Research, Business Development and Venture Funds will be available for discussions and exchange.
To have a constructive exchange, the target group should be:
- Start-ups & Biotechs in the field of pharmaceutical development (all indications)
- Technology-oriented companies in this field, including digital health companies and AI approaches relevant to pharmaceutical issues, and
- Academic PIs who are thinking about a spin-off based on their scientific ideas and wish to get in touch with pharma at an early stage.
More information on Boehringer Ingelheim’s focus areas can be found here.
The event is free of charge. Registration is required!
Places are limited, first come, first served!
This event is supported by the Cluster HealthCapital Berlin-Brandenburg.
For more informations please contact volker.erb@noSpamberlin-partner.de or phone 030 46302-515